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Objective: This article describes the development and testing of the Functional Recovery tool (FR tool),
a short instrument for assessing functional recovery during routine outcome monitoring of people living
with serious mental illnesses. Methods: To assess functional recovery, mental health professionals
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conducted semistructured interviews with people living with serious mental illnesses on three areas of
social functioning: daily living and self-care, work and study, and social contacts. Functioning in each
of these areas over the past 6 months was rated on a 3-point scale: 0 (independent), 1 (partially
independent), and 2 (dependent). The dichotomous overall outcome of the tool is defined as independent
functioning in all areas. We analyzed interrater and test–retest reliability, sensitivity to change, and
correlations with constructs that are assumed to be similar to the FR tool (quality of life in daily living,
work, and social contacts) or divergent from it (symptomatic functioning). Results: The FR tool was
administered to 840 individuals with serious mental illnesses in Dutch mental health care services, 523
of whom were followed up for 1 year (response rate 62%). The tool was easy to complete and was
appropriate for policy evaluation and practice. However, when it was combined with more elaborate
instruments, it added little extra clinical information. Interrater and test–retest reliability, convergent and
discriminant validity, and sensitivity to change were rated sufficient to good. Conclusions and Impli-
cations for Practice: The FR tool could be a useful measure of functional recovery in addition to current
measures of symptomatic remission and personal recovery in routine outcome monitoring.
Keywords: social functioning, functional recovery, serious mental illnesses, routine outcome monitoring
Supplemental materials: http://dx.doi.org/10.1037/prj0000320.supp
Since the turn of the century, various countries—including the
Netherlands—have used routine outcome monitoring for treatment
evaluation and to shape health policy regarding people with seri-
ous mental illnesses. By periodically assessing service users, rou-
tine outcome monitoring facilitates shared decision making on
treatment. Its results can also be used to compare service outcomes
for national health policies.
As the concept of recovery related to serious mental illnesses
has become more important in mental health care, routine outcome
monitoring should incorporate recovery-oriented instruments.
These should transcend the traditional concept of recovery, which,
defined as “total absence of symptoms,” does no justice to the
personal side of recovery and fails to acknowledge that illness and
recovery are best described as a continuum (Drake, Noel, &
Deegan, 2015; Lloyd, Waghorn, & Williams, 2008; Slade &
Longden, 2015).
In recent years, this has led to the introduction of the more
optimistic concept of symptomatic remission, which, by analogy
with chronic somatic diseases such as asthma, addresses the fact
that a state of remission can exist while some residual symptoms
interfere with daily functioning (Andreasen et al., 2005; Heering et
al., 2015; van Os, Burns, et al., 2006; van Os, Drukker, et al.,
2006). Remission does not necessarily mean full recovery, which,
according to van Os, Burns et al. (2006), is a longer-term, more
comprehensive goal. Recovery is first of all a personal process in
which individuals endeavor to resume their lives and overcome the
challenges brought by their disorder (Anthony, 1993; Deegan,
1996; Shepherd, 1991). Its key components are finding and
maintaining hope, reestablishing identity, building a meaning-
ful life and connection with others, and taking responsibility
(Andresen, Oades, & Caputi, 2003; Leamy, Bird, Le Boutillier,
Williams, & Slade, 2011; Noordsy et al., 2002). Recovery can
also be specified in a number of domains besides those of
symptoms and personal recovery; they include the domains of
physical health and cognitive functioning and the domain of
social functioning (Lloyd, Waghorn, Best, & Gemmell, 2008;
Westcott, Waghorn, McLean, Stratham, & Mowry, 2015),
which is the focus of this article.
The many recovery measures developed in recent decades have
had a wide variety of definitions and goals (Campbell-Orde,
Chamberlin, Carpenter, & Leff, 2005; Shanks et al., 2013). How-
ever, many such measures overlook the perspective of people with
serious mental illnesses, which include having a secure home,
meaningful activities, and a supportive social network (Drake et
al., 2015). In addition, no gold-standard measure of functional
recovery has been developed, which is why it is recommend to test
new ones that are short and easy to administer, valid in terms of
real-world outcomes, and sensitive to change (Mausbach, Moore,
Bowie, Cardenas, & Patterson, 2009).
In this context, Harvey and Bellack (2009) explored the idea of
evaluating functional recovery in a remission model analogous to
symptomatic remission. In their opinion, this could contribute to a
more appealing, meaningful evaluation of the goals of mental
health interventions. They define the outcome of functional recov-
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ery as remission of impairments in daily functioning with a focus
on the three domains of residential and independent living, work,
and social relationships for a period of at least 6 months (similar to
the definition of symptomatic remission). Although it is possible to
separate real-world outcomes and a person’s ability to perform in
these domains, the authors stress that the final index of functional
recovery should be real-world outcome.
In the Netherlands, “remission” is also discussed as an inspiring
concept for evaluating progress toward mental health goals fo-
cused on recovery. A national task force reached consensus on
compiling a set of short instruments on the trinity of (1) symp-
tomatic remission, (2) personal recovery, and (3) functional recov-
ery to be included in a national scale for routine outcome moni-
toring targeting individuals with serious mental illness (SMI)
across inpatient and outpatient treatment settings. One purpose of
the taskforce is to evaluate progress toward the national objective
of promoting recovery among people with SMIs (Phrenos Dutch
National Remission Committee, 2014).
Although several excellent measures of role functioning and
social inclusion have already been developed (such as Birchwood,
Smith, Cochrane, Wetton, & Copestake, 1990; Lloyd et al., 2008;
Stewart et al., 2010; Westcott et al., 2015), they are not a perfect
fit with the criteria for this national instrument for routine outcome
monitoring on functional recovery. Any new instrument should
thus (a) focus on measuring real-world outcomes in daily living
and self-care and in work, study, and social contacts; (b) be short
and therefore easy to administer in combination with other instru-
ments, thereby covering the full spectrum of recovery domains;
and (c) have a dichotomous (yes/no) outcome for remission in
impairments in functioning that is parallel to the concept of symp-
tomatic remission.
In this study, we evaluated the validity, reliability, and usability
of such an instrument, the Functional Recovery (FR) tool, a newly
developed short instrument for routine outcome monitoring.
Method
Participants
The research was conducted between 2012 and 2013. The par-
ticipants were mental health care organizations working in eight
different regions of the Netherlands. These participants were iden-
tified from two sources: the records of service recipients in Flex-
ible Assertive Community Treatment (F-ACT) teams (for the
F-ACT model, see van Veldhuizen, 2007) and the records of
organizations for sheltered and supported living (n  840).
Under Dutch law, studies using anonymous data from ques-
tionnaires in routine outcome monitoring procedures do not
require formal approval by the Medical Ethical Committee, nor
is informed consent needed if these data are sampled without
placing an additional burden on the service recipients (Mulder
et al., 2010).
Development of the FR Tool
The Dutch national remission taskforce was developed with the
purpose of reaching consensus on measures to be used in routine
outcome monitoring for individuals with SMIs. Service users and
professionals were consulted on interim findings and participated
in joint meetings.
The taskforce specified a number of criteria for an instrument
for assessing social functioning: (1) focus on the main social
recovery domains; (2) suitable for routine outcome monitoring
across networks of inpatient, outpatient, and sheltered care; (3)
easy to administer; (4) aggregation of information into a dichoto-
mous rating (yes/no) covering a 6-month period; and (5) com-
pleted by service users and clinicians together. If the latter is not
possible, selective loss to follow-up should be prevented by basing
the assessment on other sources (relatives, medical records;
Young, Grusky, Jordan, & Belin, 2000).
Functional recovery was assessed in three domains: (1) daily
living and self-care, (2) work (including that performed at home by
housewives and househusbands) and study, and (3) social contacts.
The importance of these areas was broadly agreed upon by groups
of professionals and service users who drafted the national action
plan.
Scoring and Weighting
Schedule 1 (see online supplemental Appendix) presents a
full description of the instrument. The FR tool can be admin-
istered jointly by the clinician and the individual. The scoring
applies to the adult population, not to children or elderly people
( 65 years). For each domain, functional recovery is assessed
from a social perspective. A crucial question for each individual
concerns the level of functioning expected on the basis of his or
her social context and age, that is, without reference to the
limitations resulting from mental health problems. To assess
functional recovery, it is also important to determine which
skills an individual has for functioning autonomously for each
domain without the help of others. When tasks are taken over by
others, the rater has to decide if the individual is capable of
doing these tasks independently if needed. Scores refer to the
greater part of the time that has elapsed in the past 6 months.
There are four scoring alternatives:
Score 0: The problem is absent, and independent functioning
is scored if no support is needed in this domain.
Score 1: A problem is present that is marginal or covered by
support.
Score 2: A serious problem is present that is insufficiently
covered by support.
Score 9: Little or no information is available for assessing the
domain.
To facilitate proper scoring, the instructions for the FR tool
provide examples. The scores on the three separate domains are
added to obtain a total sum score for functional recovery (score
0 – 6). A sum score of 0 indicates full functional recovery, a
score of 1 indicates partial recovery, and higher scores (2– 6)
indicate no functional recovery. Ultimately, the overall out-








































































































Other Instruments Used to Measure Convergent and
Discriminant Validity
Convergent and discriminant validity are both ways of assessing
construct validity by examining the strength of the relationship
between the scores that result from two different measures. Con-
vergent validity is assumed if the expected association is found
between two measures that are expected to point in the same
direction (Westen & Rosenthal, 2003). Discriminant validity is
assumed if there is a weak correlation between two measures that
are expected to be dissimilar due to differences in the constructs
measured or in the measuring procedures—for instance, if the
measure is a self-report instrument or is based on an observer’s
rating (Eklund & Leufstadius, 2007; Eklund & Bejerholm, 2017).
In this study, we used several instruments that are often used in
routine outcome monitoring procedures in the Netherlands (Deles-
paul, 2015) and can be used to evaluate discriminant validity
(dissimilar constructs) and convergent validity (comparable con-
structs). It was assumed that instruments that measure the construct
of psychiatric symptoms would be relatively dissimilar to the
construct of the FR tool. This assumption was based on research
outcomes that suggest a weak to moderate association between
symptom remission and remission of limitations in daily function-
ing (McGurk & Mueser, 2004; Priebe, 2007; Sarfati et al., 2017;
Ventura, Hellemann, Thames, Koellner, & Nuechterlein, 2009;
Wunderink, Nieboer, Wiersma, Sytema, & Nienhuis, 2013).
Since social functioning and needs for care and quality of life in
areas of daily living are more strongly associated (Drake et al.,
2016; Salyers, Becker, Drake, Torrey, & Wyzik, 2004; Slade,
Leese, Cahill, Thornicroft, & Kuipers, 2005), it was also assumed
that instruments targeting them would be more comparable to the
FR tool.
Measures Used for Symptomatic Remission
The following instruments were employed in the routine out-
come monitoring in one or more of the participating organizations.
The Positive and Negative Syndrome Scale–8 (PANSS-8) con-
tains a selection of eight core items from the total of 30 items in the
PANSS (Kay, Fiszbein, & Opler, 1987). These items are delusions,
unusual thought content, hallucinations, conceptual disorganiza-
tion, mannerism, blunted affect, social withdrawal, and lack of
spontaneity. The scoring options on a Likert scale vary between 1
(absent) and 7 (extreme). On the basis of the criteria of the U.S.
and European schizophrenia remission working groups (Emsley,
Chiliza, Asmal, & Lehloenya, 2011; van Os, Burns, et al., 2006;
van Os, Drukker, et al., 2006), these eight core symptoms represent
a level of impairment consistent with symptomatic remission of
psychotic disorders. Following the instructions of the remission
working groups, we dichotomized the eight PANSS items into
remission or no remission. A score of less than 4 (moderate
severity) on all items represents symptomatic remission; a score
greater than or equal to 4 (moderate severity) on at least one item
represents no remission (Andreasen et al., 2005).
The Health of the Nation Outcome Scales (HoNOS; Wing et al.,
1998; Mulder et al., 2004) is used to measure health and social
functioning of individuals with SMI. The HoNOS consists of 12
items on problems in behavior, impairment in functioning, psychi-
atric symptoms, and problems in social contacts, each rated on a
5-point scale: 0 (no problem), 1 (minor problem), 2 (mild prob-
lem), 3 (moderate severe problem), and 4 (severe to very severe
problem). The 12 items are rated over a period of 2 weeks. Their
sum provides a total score (range 0–48). The HoNOS has good
psychometric characteristics. To validate our FR tool, we recat-
egorized the three HoNOS symptom items (depression, psychotic
problems, and other psychiatric problems) into a dichotomous
rating of symptom remission (yes/no) following the method of
Kortrijk, Mulder, Van der Gaag, and Wiersma (2012). If all three
items were below the level representing a clinical problem (score
of 0 or 1), a score of zero (in remission) was assigned. If at least
one of the three HoNOS items had a score of 2 or higher, a score
of 1 (no remission) was given.
A measurement of symptoms, the Brief Psychiatric Rating
Scale–24 (BPRS-24; Ventura, Green, Shaner, & Liberman, 1993),
was included only for one mental health organization. The BPRS
is a scale that a clinician or researcher can use to measure depres-
sive symptoms and positive and negative psychiatric symptoms.
Each symptom is rated on a Likert scale between 1 (no problem)
and 7 (severe problem). For our analysis, we calculated the mean
total scale score.
The Global Assessment of Functioning (GAF; American Psy-
chiatric Association, 1994) contains one item in the domain of
symptoms and disabilities in daily life and a score range from 100
(high functioning) to 1 (severely impaired). A score  60 points
indicates adequate functioning.
Measures Used With Regard to Functional Recovery
The HoNOS functioning subscale includes two items: problems
in daily living skills and problems in social contacts. A score of 0
(remission) is assigned if these items are both  2; a score of 1 (no
remission) is assigned if at least one of the items has a score of 2
or higher.
The Camberwell Assessment of Need Short Appraisal Schedule
(CANSAS) assesses service users’ needs in the past month in 22
health and social-life domains (Slade et al., 2005). For each do-
main, possible ratings are unmet need (serious problem regardless
of any help received), met need (no/moderate problem because of
help given), no need, or not known. We used the service-recipient
version (CANSAS-P) and analyzed the mean sum score for needs
for care in three areas for which we combined the following
CANSAS domains: daily living (housing, food, housekeeping, and
self-care), work (daily activities and employment), and social
contacts (social contacts and intimate relationships).
Quality of life was assessed using the Manchester Short Assess-
ment of Quality of Life (MANSA; Priebe, Huxley, Knight, &
Evans, 1999), a 16-item measure that comprises 4 objective and 12
subjective questions. The subjective items assess satisfaction with
life as a whole, with job (or sheltered employment, training/
education, or unemployment/retirement), and with financial situ-
ation, number and quality of friendships, leisure activities, accom-
modation, personal safety, people the individual lives with (or
living alone), sex life, relationship with family, physical health,
and mental health. Each item is rated on a 7-point satisfaction
scale, from 1 (couldn’t be worse) to 7 (couldn’t be better). The
eight regional mental health organizations participating in the
research used different local versions of the MANSA (with a
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show large overlap with the domains of the FR tool. For the
comparison with the FR tool, we calculated the mean scores on the
available items.
Additional Information
Sociodemographic and other clinical characteristics were taken
from service-recipient records that were updated yearly. We also
added two questions (7-point Likert scale) on clinical relevance
and difficulties in using the tool according to the raters in five of
eight institutions (n  367).
Data on the difficulty and relevance of the assessment (Likert
scale 1–7) were available for 324 (88%) and 320 (87%) of the
assessments in five institutions (n  367).
Finally, for a combined test of interrater reliability and test–
retest reliability, 106 service recipients participated in an extra
measurement after 2 weeks. In most cases, the first rater was the
responsible mental health nurse; in a small number of cases, it was
a psychologist working as a research assistant. In most cases, the
second rater was the individuals’ psychiatrist or psychologist.
Procedures
The FR tool was administered together with the other instru-
ments used in the yearly regular routine outcome monitoring
procedures of one or more of the participating organizations. The
FR tool was added at the end of the questionnaire for the clinicians
after longer measures such as the CANSAS and HoNOS. The tool
was completed by the clinician and patient together.
Statistical Analyses
Internal reliability of the FR tool was evaluated by examining
Cronbach’s alpha and the Spearman’s rho correlations between
three domains. For the combined test of interrater and test–retest
reliability, we calculated the percentage of agreement and a weighted
Cohen’s kappa (a weight of 0.7 for a 1-point difference, instead of
0.5 unweighted). For the convergent and discriminant validity, we
used descriptive and analytical statistics (percentages, chi-square
test, Spearman’s rho correlation, and analysis of variance). The
significance level was set at p  .05. For the cutoff values of
significant clinical change at the follow-up after 1 year, we calcu-
lated the reliable change based on the standard deviation of the
sum score (0–6) of the FR tool at the start of the study and
Cronbach’s alpha.
Results
Characteristics of the Participants
The FR tool was administered in 2012 to 840 individuals with
SMIs. Their characteristics are shown in Table 1. One year later,
523 of these individuals were followed up (62% of the baseline
sample).
For the purposes of the 1-year follow-up, many service recipi-
ents could not be reached or were unable to participate because
they were out of care, had moved to another region, had died, or
were not willing to take part in the routine outcome monitoring
again. In various respects, the composition of the group of partic-
ipants who participated in the follow-up was different from the
group that was lost to follow-up: The percentage of women was
lower in the follow-up group (34% vs. 43% of the group that did
not participate in the follow-up; p  .05), more participants were
of non-Dutch origin (23% vs. 17%; p  .05), and of the partici-
pants in the follow-up, a smaller percentage had undergone invol-
untary hospital admission (5% vs. 10%; p  .01). At follow-up,
levels of education, living situation, psychiatric diagnosis, mental
health care settings, and the date-1 functional recovery level did
not differ significantly between participants and nonparticipants at
the follow-up assessment.
Outcome of FR Tool
A total sum score for functional recovery was calculated for
almost all individuals except for 13 with an incomplete/invalid
measurement on the FR tool (1.5%). There were high rates of
functional recovery in the separate domains (a quarter to a third).
The dichotomous overall score indicated that 14% of the individ-
uals were in full functional recovery at the first measurement (see
Table 2). Analyses of the relationship between demographic and
diagnostic characteristics and the total score on the FR tool indi-
cated that people in functional recovery were more likely to be
female (18% vs. 11% men; p  .013), to have been born in the
Netherlands (15% vs. 8%; p  .027), and to have been diagnosed
with “other psychotic disorders” or other disorders (19% “other
psychotic disorder” and 32% “other disorders” vs. 13% and 23%;
p  .012). The service recipients’ mean age and the raters’
professional background were not significantly related to func-
tional recovery.
Regarding the difficulty and relevance of the assessment, we
found that scoring was reported to be easy in 93% of the 324
assessments (score 5–7 on Likert scale, mean score 6.3; SD  1.2);
34% of the 320 assessments were considered relevant to other
Table 1
Sociodemographic and Clinical Characteristics of the Study
Sample (n  840)
Variable Total n %/M n/SD
Age, mean SD 840 44.4 12.1
Male, % n 840 62.9 528
Dutch ethnicity, % n 648 79.5 515
Living situation, % n 801
Alone 43.2 346
With others (e.g., partner/family) 27.0 216
Inpatient or sheltered living 29.8 239
Psychiatric diagnoses, % n 778
Schizophrenia 63.2 492
Other psychotic disorder 13.9 108
Mood, bipolar, anxiety disorder 9.1 71
Personality disorder 4.9 38
Substance abuse or dependence disorder 4.5 35
Other disorder 4.4 34
Mental health care setting, % n 729
Outpatient 67.4 491











































































































information gathered with instruments for routine outcome moni-
toring and in clinical practice (score 5–7 on Likert scale, mean
score 3.8; SD  2.1).
On average, it took 7 minutes longer to administer the FR tool
together with the other instruments for routine outcome monitoring
than it did to administer these instruments alone.
Reliability
The internal reliability of the functional recovery scale was
average to good (Cronbach’s alpha  0.70). The correlation be-
tween the domains was 0.42 for the living domain and the work
and study domain, 0.44 for daily living and social contacts, and
0.45 for the FR work and study domain and the social contacts
domain (all ps  .001).
The combined test of interrater reliability and test–retest reli-
ability (n  106) reported as a percentage agreement was good
(91% for remission of impairments in daily living, 90% for remis-
sion in work and study, 89% for remission in social contact, and
90% as the total score of the FR tool). The weighted kappa values
(a weight of 0.7) were acceptable: 0.68 for daily living, 0.62 for
work and study, and 0.55 for social contacts. The total score of the
FR tool was 0.53.
Discriminant and Convergent Validity
In Table 3, the results of the analyses of discriminant and
convergent validity are presented. Further examination of the
results shows that symptomatic remission analyzed with the
PANSS or the HoNOS symptomatic remission criteria gave
the same outcome as the FR tool in respectively only 21% (41
of 197) and 17% (30 of 181) of the cases, while symptomatic
nonremission was accompanied in many cases by functional
nonrecovery: 90% (276 of 306) for PANSS and 90% (405 of
450) for HoNOS. Of persons in full functional recovery, 58%
(41 of 71) were also in symptomatic remission according to the
PANSS. Also, of the persons in functional nonrecovery, 36%
(156 of 432) were in symptomatic recovery. As for the HoNOS
symptomatic remission criteria, these percentages were respec-
tively 40% (symptomatic remission of functional recovery cas-
es: 30 of 75) and 27% (symptomatic remission of functional
nonrecovery cases: 151 of 556).
Table 2
Functional Recovery (FR) per Domain: Daily Living and Self-Care, Work and Study, Social











Full recovery, % (n) 35.1 (294) 23.8 (199) 37.1 (308) 13.7 (113)
Partial/no recovery, % (n) 64.9 (542) 76.2 (636) 62.9 (522) 86.3 (714)
Table 3
Functional Recovery (FR), Discriminant Validity, and Convergent Validity
Variable FR: Full recovery FR: Partial—no recovery Significance
Discriminant validity
SR-PANSS, % (n) (n  71) (n  432)   .15
Symptomatic remission (n  197) 8.2 (41) 31.0 (156) p  .001
No symptomatic remission (n  306) 6.0 (30) 54.9 (276) n  503
SR-HoNOS, % (n) (n  75) (n  556)   .09
Remission (n  181) 4.4 (30) 24.5 (151) p  .021
No remission (n  450) 6.5 (45) 64.6 (405) n  631
BPRS (mean score, SD) 32.8 (8.0) 46.1 (14.1)   .36
p  .001
n  99




HoNOS functioning, % (n) (n  75) (n  555)   .19
Full remission (n  239) 7.5 (47) 30.5 (192) p  .001
Partial or no remission (n  391) 4.4 (28) 57.6 (363) n  630
MANSA (mean score, SD) 5.2 (1.0) 4.8 (1.1)   –.12
p  .001
n  761
Note. Values are presented as percentages or mean scores (absolute numbers/SD); significance in Spearman’s
rho (). SR-PANSS  Symptomatic Remission-PANSS; SR-HoNOS  Symptomatic Remission-HoNOS;
BPRS  Brief Psychiatric Rating Scale; GAF  Global Assessment of Functioning; HoNOS  Health of the
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Agreement was also comparable for the separate FR domains,
where the correlation was weak but statistically significant, rang-
ing from   0.09 to 0.20. Functional recovery correlated also
weakly with symptomatic remission according to a HoNOS total
score (  0.16, p  .001) and according to the PANSS total score
(  0.23, p  .001).
Examination of the relationships between functional recovery
and continuous measures of functioning on the GAF and symp-
toms on the BPRS indicated stronger associations. Specifically,
Spearman’s correlations were statistically significant in all cases
and in the expected direction. However, the associations were of
moderate strength: 0.34 to 0.22 for the GAF and 0.31–0.39 for
BPRS (but stronger than for symptomatic remission measured with
PANSS).
As for convergent validity, the correlation of FR and HoNOS
functioning (items on “social relationships” and “all-day living
skills”) was statistically significant (with   0.19 [Table 3]).
Further examination showed that of the persons in full functional
recovery according to the HoNOS (n  239), 19.7% (n  47) were
also fully recovered according to the FR tool. In contrast to this
finding, however, 92.8% (n  363) of the nonrecovered patients
according to the HoNOS functioning items (n  391) were also
not recovered according to the FR tool.
The mean scores on the domains of CANSAS-P “daily living,”
“work/activities,” and “social contacts” were correlated with the
outcome on the domains of the FR tool (measured with Spear-
man’s rho; see Table 4). In particular, the domain of CANSAS-P
on “daily living” supported the FR tool for “daily living” and the
total score.
The MANSA correlated positively with functional recovery:
The mean MANSA scores were the highest for “full functional
recovery” (5.2) and the lowest for “nonrecovery” (4.8; p  .001).
Stability and Sensitivity to Change
The correlation between total scores of the FR tool at baseline
and the follow-up after 1 year was statistically significant; this was
the case for the dichotomous measure (functional recovery or
nonrecovery,   0.35; p  .01, n  505) and for the continuous
maximum 0–6 sum score of the scale (  0.50; p  .01). On the
0–6 sum score, 32% of the individuals had the same scores, 35%
had higher scores by 1 or more points (representing an improve-
ment in terms of functional limitations), and 34% had lower scores
by 1 or more points—in other words, they worsened. Thus, there
was a change between the two measurement points for 68% of the
patients. For both assessments, 6% of the individuals remained
stable in full functional recovery (score 0).
Validation of the change in functional recovery status showed
that changes in the total score were not or only weakly corre-
lated with sociodemographic and clinical characteristics and
changes in symptom scores (PANSS, HoNOS symptoms, and
GAF) or changes in HoNOS functioning and quality of life
(MANSA). There were no statistically significant relationships
between the difference scores for functional remission based on
the FR tool and the other scales. We define reliable change
(95%) as a difference of 3 or more points between baseline and
follow-up on the FR sum score (ranging 0 – 6). This applied to
14% of the participants.
Discussion
Outcomes
On the basis of our analyses, we conclude that the internal
coherence of the three dimensions of functional recovery and the
interrater reliability are adequate. The pattern of associations of the
FR tool with the convergent instruments and the divergent instru-
ments was not very strong; however, the results were in the
expected direction. As for discriminant validity, symptomatic re-
mission according to the PANSS or HoNOS symptom items co-
incided with functional recovery in one fifth of the cases, while the
lack of symptomatic remission corresponded in almost all cases
with functional nonremission. However, we also found that when
symptomatic remission was absent, the chances of functional re-
covery were significantly lower. This means that symptomatic
remission does appear to contribute to functional recovery.
Regarding convergent validity, functional recovery measured
according to the HoNOS social functioning items had little overlap
with remission of impairments according to the FR tool, while
there was a large overlap between these two functional measures
for nonremission. The CANSAS-P as a measure for need for care
and functioning—with mean scores on the subareas of daily living,
work, and social contacts—supported the comparable domains of
the FR tool.
With respect to stability and sensitivity to change, the percent-
ages for full remission and partial or no remission at the start of the
study and 1 year later were practically the same. About one third
of the service recipients improved between the two assessments,
and similar proportions remained the same or deteriorated. In other
words, there was a large change in the percentage of persons in
functional recovery in the individuals with SMI between the two
measurements (60%). However, the percentage of persons who
exhibited a reliable change (by 3 points or more) was smaller,
Table 4










CANSAS—living (n  106) .66 .35 .22 .34
CANSAS—work (n  96) .14 .22 .05 .10
CANSAS—social contacts (n  95) .09 .11 .28 .15
Note. CANSAS  Camberwell Assessment of Need Short Appraisal Schedule.







































































































more than 10%, which seems to be consistent with the picture of
the group of people with SMI. Only 6% remained stable and in full
functional recovery.
Representativeness of the Sample
Considering the sociodemographic characteristics, the represen-
tativeness of the sample (excluding children and seniors) is good,
although individuals with a psychotic disorder and inpatients in
mental health care services and sheltered living organizations may
be overrepresented relative to estimates of SMIs in the Nether-
lands’ general population (Delespaul & de consensusgroep EPA,
2013). Information on our participants’ characteristics was limited:
For instance, it was impossible to retrieve from service-recipient
records about whether a person actually worked or was studying.
Roughly one in seven service recipients had been in full functional
recovery over the past 6 months; in several domains, the propor-
tion was over one third. This finding may indicate that full remis-
sion in impairments of functioning in separate domains is not
unusual.
Our research also indicates that symptomatic and social limita-
tions are moderately related and therefore also fluctuate semi-
independently of one another. This is consistent with results of
other Dutch studies (Kortrijk et al., 2012; Wunderink et al., 2013).
Almost one fifth of the individuals with SMIs achieved symptom-
atic and functional recovery after 1 or 2 years, and half of those in
functional recovery did not achieve symptomatic remission in the
same period.
Comparison With Other Instruments
As we combined the testing of the tool with regular procedures
for routine outcome monitoring, there was only limited overlap of
comparable functional measures with the FR tool. The measures
we used (Functional Remission-HoNOS, CANSAS, MANSA) did
not yield outcomes that are well comparable.
It is important to consider how HoNOS is related to functional
recovery, given that it is often used for routine outcome monitoring
in long-term mental health care. In fact, the HoNOS is a hybrid
instrument consisting of 12 items with highly varied content. The
focus of the convergent validity lies in the two functional items on
social relations and all-day living skills. Research shows a weak
correlation between the two items and the FR tool. An important
comment in this respect is that the content of the assessment of FR
using HoNOS differs from that using the FR tool: While HoNOS
covers a period of 2 weeks, the FR tool covers 6 months; while
HoNOS is rated without regard to providing help and support, the
FR tool assesses the independence of the service recipients without
support. This is important, for instance, for people who live in
residential settings for long-term care, who, due to their lengthy
stay in supported living, may be in functional recovery according
to HoNOS but not according to the FR tool.
As for the convergent validity, the CANSAS domains studied
correlated most strongly with the comparable domains of the FR
tool, particularly with respect to the domain of daily living, and to
a lesser extent the domains of work and social contacts. The
modest correlations were as could be expected since there was a
difference in time frame between the FR tool (6 months) and
CANSAS-P (past month), and since independent functioning and
care needs are related but not identical concepts. For instance, one
can function well at work and daily activities but still have care
needs in these areas.
Scoring and Weighing
The question arises as to the relevance to mental health care
practice of recovery scores of 1 (partial recovery) and 2 or above
(no functional recovery). These scores could be used to set prior-
ities in treatment and to determine the support level needed by a
service-recipient group. According to our results, the sum score of
the FR tool, which can range from 0 to 6, has no floor or ceiling
problems (i.e., no accumulation of cases at the low or high ends of
the scale) but is distributed equally over the seven categories. The
distribution of scores over the entire range of the scale is favorable
from a psychometric point of view (allowing greater change in
scores). It also facilitates differentiation in the individual domains
of functioning, which was also established by the FR total sum
score rather than by the dichotomous overall score on the FR tool
(yes/no).
Application in Clinical Practice and National Routine
Outcome Monitoring
In two thirds of the cases, the clinicians were skeptical about the
relevance of the FR tool to clinical practice, while one third found
it to be of direct added value to treatment. The background to these
responses is that many participants were long-time service users
with the same teams and that the instrument had been combined
with more elaborate instruments such as CANSAS-P. Adding an
additional brief and global assessment in such cases did not always
provide clinicians with additional information. However, we ex-
pect that the functional recovery tool also may be useful on a
national level to evaluate progress toward the national objective of
promoting recovery among people with SMIs.
When measuring symptomatic remission and functional recov-
ery, routine outcome monitoring is not complete. It is important to
include participants’ perspectives on personal recovery (Davidson,
Lawless, & Leary, 2005) by using instruments that address the
subjective process dimension of recovery (e.g., Boevink, Kroon,
Delespaul, & van Os, 2017; Neil et al., 2009).
Conclusion
This study of the FR tool supports its relevance as an additional
instrument for routine outcome monitoring. In view of its validity
and reliability, it can contribute to measuring functional recovery
from a social perspective for this population. If it becomes part of
regular procedures for routine outcome monitoring, it could be a
useful addition to current measures of symptomatic remission and
personal recovery.
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